Modern Diagnostic IPO: 560% subscription on Day1; GMP rising | See details
On Dec 31, Modern Diagnostic IPO was subscribed 5.60 times overall -- 5.51 times in the individual investors category, 4.01 times in QIB (Ex Anchor), and 7.96 times in the NII. The IPO intends to raise Rs 36.89 crore from the market through issue of 0.41 crore fresh shares.
Kolkata: The very last IPO of 2025 was a success on the first day of bidding itself. On Dec, when the bidding process of the issue opened, Modern Diagnostic IPO was subscribed 5.60 times overall -- 5.51 times in the individual investors category, 4.01 times in QIB (Ex Anchor), and 7.96 times in the NII. It is significant that the QIB portion was subscribed more than 4 times. QIBs or qualified Institutional Buyers are organisations such as banks and mutual funds which have deep pockets to invest big sums and the skills to analyse a public issue threadbare.
The issue will close on January 2. The application process for the Rs 36.89-crore issue began on the last day of 2025. Modern Diagnostic & Research Centre is a diagnostic chain offering a wide range of pathology and radiology services such as diagnostic tests, home specimen collection, online reports and customised test packages for institutional customers and patients. It has 21 centers of which 18 are laboratories and three are diagnostic centers which are spread across eight states.
Modern Diagnostic IPO GMP
According to investorgain, Modern Diagnostic SME IPO GMP stood at Rs 13 in early morning of Jan 1. Considering a price band of Rs 90.00, Modern Diagnostic SME IPO's estimated listing price could be Rs 103 and the listing gain will be 14.44%.
Modern Diagnostic SME IPO GMP stood at Rs 10 in early morning of Dec 31 and then rose to Rs 13 later in the day. It jumped to this level from zero on Dec 30. However, it must be remembered that GMP is an unofficial gauge, is volatile and cannot guarantee any listing gain (or loss).
Modern Diagnostic IPO price band, lot size
The Modern Diagnostic IPO price band is Rs 85-90. The minimum investible lot for a retail investor in this IPO is 1,600 shares for which he/she will have to pay an application amount of Rs 2,88,000 based on the upper price. For HNIs the minimum lot size for investment is three lots or 4,800 shares.
Beeline Capital Advisors is the book running lead manager, while MUFG Intime India has been appointed the registrar of the issue and the Market Maker of the company is Spread X Securities.
Modern Diagnostic IPO key dates
Bid closes: Jan 2, 2026
Allotment: Jan 5
Refund: Jan 6
Credit of shares to demat: Jan 6
Listing: Jan 7
Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, InvITs and any form of alternative investment instruments and crypto assets.